Catalyst Pharmaceuticals, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC CPRX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

279,281

Value ($000)

6,518

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	6,518	0.0%	279,281	12/31/2025
2025 Q3	11/14/2025	5,463	0.0%	277,301	9/30/2025
2025 Q2	8/14/2025	12,709	0.0%	585,671	6/30/2025
2025 Q1	5/19/2025	12,763	0.0%	526,297	3/31/2025
2024 Q4	2/14/2025	5,508	0.0%	263,905	12/31/2024
2024 Q3	11/14/2024	4,696	0.0%	236,222	9/30/2024
2024 Q2	8/14/2024	3,890	0.0%	251,120	6/30/2024
2024 Q1	5/15/2024	1,845	0.0%	115,744	3/31/2024
2023 Q4	2/14/2024	1,941	0.0%	115,489	12/31/2023
2023 Q3	11/13/2023	1,350	0.0%	115,489	9/30/2023
2023 Q2	8/11/2023	2,273	0.0%	137,077	6/30/2023
2023 Q1	5/15/2023	2,273	0.0%	137,077	3/31/2023
2022 Q4	2/14/2023	2,361	0.0%	126,951	12/31/2022
2022 Q3	11/14/2022	1,554	0.0%	121,137	9/30/2022
2022 Q2	8/12/2022	855	0.0%	121,968	6/30/2022
2022 Q1	5/16/2022	1,043	0.0%	125,758	3/31/2022
2021 Q4	2/14/2022	1,115	0.0%	164,658	12/31/2021
2021 Q3	11/15/2021	730	0.0%	137,675	9/30/2021
2021 Q2	8/16/2021	1,164	0.0%	202,475	6/30/2021
2021 Q1	5/14/2021	899	0.0%	195,001	3/31/2021
2020 Q4	3/1/2021	651	0.0%	195,001	12/31/2020
2020 Q3	11/13/2020	289	0.0%	97,301	9/30/2020
2020 Q2	8/14/2020	463	0.0%	100,153	6/30/2020
2020 Q1	5/15/2020	387	0.0%	100,643	3/31/2020
2019 Q4	2/14/2020	352	0.0%	93,762	12/31/2019